Cargando…

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders

Lewy Body Disorders (LBDs) lie within the spectrum of age-related neurodegenerative diseases now frequently categorized as the synucleinopathies. LBDs are considered to be among the second most common form of neurodegenerative dementias after Alzheimer's disease. They are progressive conditions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manzanza, Nelson de Oliveira, Sedlackova, Lucia, Kalaria, Raj N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267936/ https://www.ncbi.nlm.nih.gov/pubmed/34248606 http://dx.doi.org/10.3389/fnagi.2021.690293

Ejemplares similares

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
por: Altay, Melek Firat, et al.
Publicado: (2022)

Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson’s disease
por: Yoo, Hajung, et al.
Publicado: (2022)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases
por: Zhang, Jiaming, et al.
Publicado: (2019)

Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
por: Brembati, Viviana, et al.
Publicado: (2023)

Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders
por: Schaser, Allison J., et al.
Publicado: (2019)

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
por: Deleidi, Michela, et al.
Publicado: (2012)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
por: Koss, David J., et al.
Publicado: (2022)

Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
por: Ingelsson, Martin
Publicado: (2016)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
por: Perra, Daniela, et al.
Publicado: (2021)

Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
por: Dhavale, Dhruva D., et al.
Publicado: (2023)

Absence of Alpha-Synuclein Pathology in the Stomach of a Patient With Prodromal Dementia With Lewy Bodies
por: Shin, Chaewon, et al.
Publicado: (2023)

Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
por: Duffy, Megan F., et al.
Publicado: (2018)

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
por: Masliah, Eliezer, et al.
Publicado: (2011)

Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
por: Duffy, Megan F., et al.
Publicado: (2018)

Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
por: Marotta, Nicholas P., et al.
Publicado: (2021)

Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
por: Bargar, Connor, et al.
Publicado: (2021)

Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders
por: Kurzawa-Akanbi, Marzena, et al.
Publicado: (2021)

Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies
por: Brockmann, Kathrin, et al.
Publicado: (2021)

SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro
por: Wu, Zhengcun, et al.
Publicado: (2022)

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice
por: Lilamand, Matthieu, et al.
Publicado: (2022)

Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders
por: Bräuer, Stefan, et al.
Publicado: (2023)

α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice
por: Uemura, Norihito, et al.
Publicado: (2023)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

Influence of RNA interference on the mitochondrial subcellular localization of alpha-synuclein and on the formation of Lewy body-like inclusions in the cytoplasm of human embryonic kidney 293 cells induced by the overexpression of alpha-synuclein☆
por: Chen, Tao, et al.
Publicado: (2012)

The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics
por: Noguchi-Shinohara, Moeko, et al.
Publicado: (2023)

Implications of post-translational modifications of IRF7 on pDC IFN-alpha response
por: Griesbeck, M, et al.
Publicado: (2012)

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
por: Sorrentino, Zachary A., et al.
Publicado: (2019)

The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
por: Marschallinger, Julia, et al.
Publicado: (2020)

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease
por: Marsal-García, Laura, et al.
Publicado: (2021)

13C and 15N Resonance Assignments of Alpha Synuclein Fibrils Amplified from Lewy Body Dementia Tissue
por: Barclay, Alexander M., et al.
Publicado: (2023)

Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis
por: Peña-Bautista, Carmen, et al.
Publicado: (2023)

Post-translational modifications of α-synuclein contribute to neurodegeneration in the colon of elderly individuals
por: XUAN, QI, et al.
Publicado: (2016)

Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications
por: Bell, Rosie, et al.
Publicado: (2021)

Idiopathic REM Sleep Behavior Disorder: Implications for the Pathogenesis of Lewy Body Diseases
por: Miyamoto, Tomoyuki, et al.
Publicado: (2011)

Post-translational modifications and their implications in cancer
por: Dutta, Hashnu, et al.
Publicado: (2023)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Distinct biological activity of Lewy body α-Synuclein strain in mice
por: Uemura, Norihito, et al.
Publicado: (2023)

Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies
por: Corbillé, Anne-Gaëlle, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ipgc1t8srdcbsgs2c0lnjuisgd